Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00329667
Other study ID # CSD 0206
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2003
Est. completion date September 2008

Study information

Verified date February 2019
Source Abbott Medical Devices
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a multi-center, prospective, non-randomized, observational study. The objectives of this study are to confirm the clinical safety and efficacy of the SJM Epic valve.


Description:

This study is a multi-centered, multi-country, prospective, non-randomized, observational study, without concurrent or matched controls, conducted under a common protocol. Bayesian methods will be used for the design and analysis of this study. The Bayesian model will determine if the data for the valve configurations are poolable. Bayesian methods also provide a means of determining the appropriate stopping time for the study based on the amount of information generated. The objectives of this study are to confirm the clinical safety and efficacy of the SJM Epic Valve by establishing the following:

- adverse effect rates

- clinical status as indicated by NYHA functional classification

- hemodynamic performance


Recruitment information / eligibility

Status Completed
Enrollment 761
Est. completion date September 2008
Est. primary completion date March 2006
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient requires replacement of the aortic and/or mitral valve (Note: Patients undergoing concomitant procedures, e.g. coronary artery bypass grafting, valve repair, are eligible for this study).

- The patient (or legal guardian) has signed a study-specific informed consent, agreeing to the data collection and follow-up requirements.

- The patient is of legal age in host country.

Exclusion Criteria:

- Patient already has a prosthetic valve, other than the aortic and/or mitral valve being replaced at this time.

- The patient requires replacement of the tricuspid or pulmonary valve.

- The patient is pregnant or nursing.

- Patient has active endocarditis.

- Patient is actively participating in the study of an investigational drug or device.

- Patient has had an acute preoperative neurological event.

- The patient is undergoing renal dialysis.

- Patient is an intravenous drug abuser, alcohol abuser or prison inmate.

- Patient has an inability or unwillingness to return for the required follow-up intervals.

- The patient had the SJM Epic Valve implanted during the clinical study but then had the bioprosthesis explanted.

Study Design


Intervention

Device:
EPIC
Surgical replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic and/or mitral heart valves

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Abbott Medical Devices

Outcome

Type Measure Description Time frame Safety issue
Primary Adverse effect rates Ongoing
Primary Clinical status as indicated by NYHA functional classification At required follow-up visits
Primary Hemodynamic performance At required follow-up visits
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Completed NCT02241109 - Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity N/A
Completed NCT03799133 - Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery N/A
Completed NCT01676727 - ADVANCE Direct Aortic Study
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT00721136 - Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation N/A
Recruiting NCT05044338 - Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease
Recruiting NCT05014750 - Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
Recruiting NCT05015829 - Diagnostic Impact of Low-dose Dobutamine Echocardiography in Low-flow Low-gradient Aortic Stenosis
Recruiting NCT05078619 - Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation N/A
Recruiting NCT06307262 - European Registry of Transcatheter Repair for Tricuspid Regurgitation
Completed NCT01624870 - CoreValve Advance-II Study: Prospective International Post-market Study
Completed NCT05708690 - Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery Phase 4
Recruiting NCT03797820 - Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly(Mrs AVS)
Recruiting NCT06077721 - Milrinone on Right Ventricular Strain in Cardiac Surgery
Not yet recruiting NCT04632914 - Effect of Trunk Stabilizing Exercises on Patients With Median Sternotomy After Heart Valve Surgery N/A
Completed NCT01477151 - Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery Phase 4
Terminated NCT03590730 - Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy
Recruiting NCT06204783 - Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions (PLUTO-II)
Enrolling by invitation NCT05775354 - Reviving Early Diagnosis of Cardiovascular Disease in the Utrecht Health Project N/A